University of Washington: Breast Neoplasms trials

The registry lists 58 Breast Neoplasms studies with University of Washington as lead sponsor. 3 are open to participants now and 23 have results posted.

Phase 1 17Phase 2 26Phase 3 1No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black WomenNot yet recruitingNCT07858825Not applicable
• Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerRecruitingNCT06518057Phase 2
• [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast CancerRecruitingNCT06502691Phase 1/2
• Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyActive, not recruitingNCT04692103Phase 2Results posted
• Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE TrialCompletedNCT04667481Not applicableResults posted
• Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in RemissionCompletedNCT02780401Phase 1Results posted
• F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyTerminatedNCT02149173Not applicableResults posted
• FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast CancerTerminatedNCT01931709Not applicableResults posted
• FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerCompletedNCT01928186Not applicableResults posted
• Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody TherapyCompletedNCT01922921Phase 1/2Results posted
• Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerCompletedNCT01908101Phase 2Results posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone TherapyCompletedNCT01720602Not applicableResults posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyCompletedNCT01153672Not applicableResults posted
• Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerCompletedNCT00992602Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT00791037Phase 1/2Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentCompletedNCT00425672Phase 1/2Results posted
• Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerCompletedNCT00416715Phase 2Results posted
• Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryCompletedNCT00407888Phase 2Results posted
• Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast CancerCompletedNCT00343863Not applicableResults posted
• Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerCompletedNCT00331552Phase 1/2Results posted
• Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II TrialTerminatedNCT00041470Phase 1/2Results posted
• A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast RadiationCompletedNCT06772181Not applicable
• Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black WomenCompletedNCT05472064
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04673448Phase 1
• Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing ChemotherapyTerminatedNCT03723863Not applicable
• Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast CancerWithdrawnNCT03644589Phase 2
• Non-contrast DWI for Supplemental ScreeningActive, not recruitingNCT03607552
• CESM ABMR Breast Cancer Screening TrialCompletedNCT03517813
• Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast CancerNo longer availableNCT02985658
• Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast CancerActive, not recruitingNCT02157051Phase 1
• Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their ChildrenCompletedNCT02129049Not applicable
• Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer TherapyTerminatedNCT01957514
• Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerCompletedNCT01874184Not applicable
• Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by SurgeryCompletedNCT01816035Phase 1
• Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast CancerTerminatedNCT01729884Phase 2
• Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer PatientsCompletedNCT01723943Not applicable
• Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive SymptomsCompletedNCT01641068Not applicable
• Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerCompletedNCT01355393Phase 1/2
• Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerWithdrawnNCT01219907Phase 1
• Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
• Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerTerminatedNCT00498901Phase 2
• Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerCompletedNCT00436254Phase 1
• Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2CompletedNCT00363012Not applicable
• PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast CancerCompletedNCT00362973
• Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast CancerCompletedNCT00343109Phase 2
• Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineCompletedNCT00228358Phase 1
• Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast CancerCompletedNCT00194766Phase 2
• Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12CompletedNCT00194753Phase 2
• Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerCompletedNCT00194740Phase 2
• Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast CancerCompletedNCT00194727Phase 2
• Enhancing Connections: Helping the Mother With Breast Cancer Support Her ChildCompletedNCT00194571Phase 3
• Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerCompletedNCT00005023Phase 1
• HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerCompletedNCT00003002Phase 1